Long-Term Safety of Elagolix With Add-Back in Women With Endometriosis-Associated Pain: 36-Month Results

被引：0
|
作者：
Simon, James [1 ]
Kim, Jin Hee [1 ]
Miller, Paul [1 ]
Ng, Juki [1 ]
Snabes, Michael [1 ]
Thomas, James [1 ]
机构：
[1] George Washington Univ, Washington, DC USA
来源：
OBSTETRICS AND GYNECOLOGY | 2023年 / 141卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
1368036
引用
收藏
页码：13S / 13S
页数：1
相关论文
共 50 条
  • [1] Long-Term Safety of Elagolix With Hormonal Add-Back Therapy in Women With Endometriosis-Associated Pain: 24-Month Results
    Simon, James
    Kim, Jin Hee
    Thomas, James
    Miller, Paul
    Snabes, Michael
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 25S - 26S
  • [2] Long-Term Safety and Efficacy of Elagolix Treatment in Women With Endometriosis-Associated Pain
    Surrey, Eric
    Taylor, Hugh S.
    Duan, W. Rachel
    Peloso, Paul
    Schwefel, Brittany
    Chwalisz, Kristof
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 4S - 4S
  • [3] Add-back therapy in the treatment of endometriosis-associated pain
    Zupi, E
    Marconi, D
    Sbracia, M
    Zullo, F
    De Vivo, B
    Exacustos, C
    Sorrenti, G
    FERTILITY AND STERILITY, 2004, 82 (05) : 1303 - 1308
  • [4] LONG-TERM THERAPY OF ELAGOLIX plus ADD-BACK THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN FOR 48 MONTHS: A SAFETY UPDATE ON BONE MINERAL DENSITY DATA OF A PHASE 3 STUDY
    Simon, James A.
    Kim, Jin Hee
    Thomas, James W.
    Ng, Juki
    Miller, Paul B.
    Chan, Anna
    Snabes, Michael C.
    FERTILITY AND STERILITY, 2023, 120 (04) : E62 - E62
  • [5] 36-MONTH BONE MINERAL DENSITY RESULTS IN WOMEN TREATED WITH ELAGOLIX plus ADD-BACK THERAPY FOR HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS
    Schnell, Vicki L.
    Ng, Juki
    Brown, Eric
    Bredeson, Liesl K.
    Thomas, James W.
    Chan, Anna
    Snabes, Michael C.
    FERTILITY AND STERILITY, 2023, 120 (04) : E227 - E227
  • [6] Long-term Effect of Elagolix on Bone Mineral Density in Women with Endometriosis-Associated Pain
    Archer, David
    Watts, Nelson
    Duan, W. Rachel
    Peloso, Paul
    Wang, Hui
    Chwalisz, Kristof
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 86S - 87S
  • [7] LONG-TERM ELAGOLIX plus ADD-BACK THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN FOR 48 MONTHS+12 MONTH POST-TREATMENT FOLLOW-UP: A SAFETY UPDATE ON BONE MINERAL DENSITY DATA OF A PHASE 3 STUDY.
    Simon, James A.
    Kim, Jin Hee
    Thomas, James W.
    Miller, Charles E.
    Chan, Anna
    Snabes, Michael C.
    FERTILITY AND STERILITY, 2024, 122 (04) : E157 - E157
  • [8] LONG-TERM EFFECT OF ELAGOLIX ON THE ENDOMETRIUM: RESULTS FROM TWO PHASE 3 EXTENSION STUDIES IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN.
    Lessey, B. A.
    Diamond, M. P.
    Agarwal, S.
    Dmowski, P.
    Duan, W. R.
    Thomas, J. W.
    Chwalisz, K.
    FERTILITY AND STERILITY, 2017, 108 (03) : E45 - E45
  • [9] Add-back therapy in the treatment of endometriosis-associated pain (vol 82, pg 1303, 2004)
    Zupi, E
    Sbracia, M
    De Vivo, B
    Marconi, D
    Zullo, F
    Exacustos, C
    Sorrenti, G
    FERTILITY AND STERILITY, 2005, 83 (04) : 1070 - 1070
  • [10] Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial
    Miller, Charles E.
    Kim, Jin Hee
    Kroll, Robin
    Simon, James A.
    Soliman, Ahmed M.
    Thomas, James W.
    Xu, Yanqing
    Ng, Juki
    Snabes, Michael C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (06) : 630e1 - 630e13
12345